Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.
about
C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma.Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinomaThe prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancerNeutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients.Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.Activities of stromal and immune cells in HPV-related cancers.DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survivalPredicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingOptimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation studyRelation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
P2860
Q37408199-CE0F68AD-B21E-45D9-BB8B-70709E27EF18Q37652983-BC4ADE66-777F-4904-8B06-3A21C8F684D5Q37702050-1D97BCA0-2009-48B8-8623-2F4EE7D0D88CQ38901921-FA3CDD4C-0FD2-4395-903B-6EEE2663D54DQ39062109-C3EFF0E2-872B-47D8-B841-139AE883DF79Q39401725-F3BE62F6-7592-4B88-9320-828FC7FD5298Q41206627-4C8E9D4F-BEB3-4F28-9FA1-174D573386B3Q41278675-75F5E060-14E5-4FC5-AE7A-B27DD0790FE4Q41342698-AD4A7B52-5218-42AE-AE98-286DF8A71D3CQ41694323-B86B1575-73C6-4412-9E44-AE58C1406B82Q45934145-F8EBC101-CB1F-48A2-A072-E925E2677F4AQ47179781-2F42863E-2EDD-43AD-8D0D-C95621BA4D4EQ48107879-876E1C4D-FFA0-4A1E-9250-2979D4646C78Q48117100-44714100-9AE2-4AF2-98AE-71A6AB418462Q48175930-D31200C4-330F-4C23-85A8-E2F20A9ED59DQ49660807-6D68FE47-1DE9-4867-9B0D-A96F980F77A5Q51440935-0BB64D2D-5E88-4AA4-BDA0-6CAE5202DF69Q52605888-643563A4-5004-46C1-89F1-1FCC0085AAEFQ55279094-8FDA613B-6E47-42EC-8DF1-D411AE4255CCQ55507801-62807DF1-E522-4C7B-B193-1E49A06D183EQ57144581-8284D2C5-92A1-41FB-A1C6-505E34FE0FEDQ57154425-9431C720-7584-4699-A213-883F83CDAC7FQ57474616-D2BF1FFE-0E0D-4095-ACB7-A1915869DB1BQ58608660-80CF436B-DC02-4775-B50B-F6841FC1E3AE
P2860
Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@nl
type
label
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@nl
prefLabel
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@en
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Neutrophil-to-lymphocyte ratio ...... neck squamous cell carcinoma.
@en
P2093
Anthony J Alberg
John M Wrangle
Kristin Wallace
Saleh Rachidi
Terry A Day
P2860
P304
P356
10.1002/HED.24159
P478
38 Suppl 1
P577
2015-06-03T00:00:00Z